This book is a comprehensive guide to the use of modern radiation therapy techniques for prostate cancer and other common and rare genitourinary malignancies. It will be an ideal resource for clinicians and trainees wishing to delve more deeply into the practical and technical aspects of radiotherapy for these malignancies and will serve to enhance day-to-day management in clinical practice. The first section is devoted to prostate cancer and includes coverage of low dose rate and high dose rate brachytherapy, conventionally fractionated, moderately hypofractionated, and ultra-hypofractionated…mehr
This book is a comprehensive guide to the use of modern radiation therapy techniques for prostate cancer and other common and rare genitourinary malignancies. It will be an ideal resource for clinicians and trainees wishing to delve more deeply into the practical and technical aspects of radiotherapy for these malignancies and will serve to enhance day-to-day management in clinical practice. The first section is devoted to prostate cancer and includes coverage of low dose rate and high dose rate brachytherapy, conventionally fractionated, moderately hypofractionated, and ultra-hypofractionated external beam radiotherapy, and proton therapy. The second section focuses on radiotherapy considerations in relation to bladder cancer, testicular cancer, renal cell carcinoma, and rare malignancies such as penile cancer and urethral cancer. Radiotherapeutic treatment of patients with genitourinary malignancies now involves unprecedented precision and complexity, and this book will enable readers to exploit fully the exciting advances that have been achieved in recent years. Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Abhishek A. Solanki, MD, is an Associate Professor of Radiation Oncology at Loyola University Chicago and Edwards Hines Jr., VA Hospital. He completed medical school and radiation oncology residency at the University of Chicago. He is currently the Director of Clinical Research, Director of Quality and Safety, and Chief of the Genitourinary Radiotherapy Service in the Department of Radiation Oncology at Loyola University Chicago. His clinical and research interests include the treatment of newly diagnosed and radio recurrent prostate cancer with image-guided brachytherapy, the use of novel imaging approaches in the management of newly diagnosed, recurrent, and oligometastatic prostate cancer, and the optimization of bladder cancer trimodality therapy. Ronald C Chen, MD MPH, is Brandmeyer Endowed Professor and Chair of Radiation Oncology at the University of Kansas Medical Center, and Associate Director for Health Equity at the University of Kansas Cancer Center. He completed medical school, radiation oncology residency and a Master of Public Health degree at Harvard. Dr. Chen has helped author several prostate cancer clinical practice guidelines for the American Society of Clinical Oncology and the American Urological Association.
Inhaltsangabe
Section 1: Prostate Cancer.- 1. The Management of Prostate Cancer.- 2. Imaging in Prostate Cancer.- 3. Androgen Deprivation Therapy.- 4. Conventional and Moderately Hypofractionated External Beam Radiotherapy.- 5. Low Dose Rate Prostate Brachytherapy.- 6. High Dose Rate Prostate Brachytherapy.- 7. Ultra-hypofractionated Radiotherapy (Stereotactic Body Radiotherapy).- 8. Proton Therapy.- 9. Post-prostatectomy Radiotherapy.- 10. Role of RT in the setting of Metastatic Disease.- Section 2: Non-prostate Genitourinary Malignancies.- 11. Bladder Cancer Radiotherapy.- 12. Testicular Cancer Radiotherapy.- 13. Renal Cell Carcinoma Radiotherapy.- 14.Radiotherapy for Rare GU malignancies (including Penile, Urethral, ureteral/renal pelvis).
Section 1: Prostate Cancer.- 1. The Management of Prostate Cancer.- 2. Imaging in Prostate Cancer.- 3. Androgen Deprivation Therapy.- 4. Conventional and Moderately Hypofractionated External Beam Radiotherapy.- 5. Low Dose Rate Prostate Brachytherapy.- 6. High Dose Rate Prostate Brachytherapy.- 7. Ultra-hypofractionated Radiotherapy (Stereotactic Body Radiotherapy).- 8. Proton Therapy.- 9. Post-prostatectomy Radiotherapy.- 10. Role of RT in the setting of Metastatic Disease.- Section 2: Non-prostate Genitourinary Malignancies.- 11. Bladder Cancer Radiotherapy.- 12. Testicular Cancer Radiotherapy.- 13. Renal Cell Carcinoma Radiotherapy.- 14. Radiotherapy for Rare GU malignancies (including Penile, Urethral, ureteral/renal pelvis).